StonvexLoading…
StonvexStonvexStonvexCore line items from ODYS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.02M | $3.96M | $3.03M | $665.00K |
Operating Income | $-18.14M | $-12.51M | $-10.63M | $-9.44M |
Net Income | $-17.04M | $-11.77M | $-9.45M | $-9.47M |
EPS (Diluted) | $-1.07 | $-1.03 | $-0.98 | $-1.33 |
Total Assets | $28.98M | $23.68M | $22.83M | $16.89M |
Total Liabilities | $3.55M | $5.43M | $5.02M | $5.11M |
Cash & Equivalents | $25.68M | $18.16M | $8.95M | $10.10M |
Free Cash Flow OCF − CapEx | $-13.76M | $-8.27M | $-10.12M | $-6.21M |
Shares Outstanding | 16.36M | 12.61M | 10.44M | 7.12M |